COATES A, 1983, Eur. J. Cancer, 19, 203, 10.1016/0277-5379(83)90418-2
DE BOER-DENNERT M, 1997, Br. J. Cancer, 76, 1055, 10.1038/bjc.1997.507
OSOBA D, 1997, J. Clin. Oncol., 15, 116, 10.1200/JCO.1997.15.1.116
CUBEDDU LX, 1992, Semin. Oncol., 19, 2
10.7326/0003-4819-95-3-352
ETTINGER DS, 1995, Semin. Oncol, 4, 6
GREGORY RE, 1998, Drugs, 55, 173, 10.2165/00003495-199855020-00002
10.1056/NEJM199003223221205
HAINSWORTH J, 1991, J. Clin. Oncol, 9, 721, 10.1200/JCO.1991.9.5.721
DEMULDER PHM, SEYNAEVE C, VERMORKEN JB et al., 1990, Ann. Intern. Med., 113, 834, 10.7326/0003-4819-113-11-834
BECK TM, 1993, Ann. Intern. Med., 118, 407, 10.7326/0003-4819-118-6-199303150-00002
LEVITT M, 1993, N Engl. J. Med., 328, 1081, 10.1056/NEJM199304153281503
10.1056/NEJM199304153281502
BREGNI M, 1991, Tropisetron plus haloperidol to amelio-rate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy. Eur. J. Cancer, 27, 561
ROILA F, 1991, J. Clin. Oncol, 9, 675, 10.1200/JCO.1991.9.4.675
SMYTH JF, 1991, Med. J., 303, 1423, 10.1136/bmj.303.6815.1423
SMITH DB, 1991, Lancet, 338, 487, 10.1016/0140-6736(91)90555-4
JOSS RA, 1994, Ann. Oncol., 5, 253, 10.1093/oxfordjournals.annonc.a058803
KRIS MG, 1989, JNCI, 81, 42, 10.1093/jnci/81.1.42
HESKETH PJ, 1989, J. Clin. Oncol., 7, 700, 10.1200/JCO.1989.7.6.700
BECK TM, 1992, J. Clin. Oncol, 10, 1969, 10.1200/JCO.1992.10.12.1969
SEYNAEVE C, 1992, A multicentre, double-blind, randomised, parallel group study. Br. J. Cancer, 66, 192
PECTASIDES D, 1997, Oncology, 54, 1, 10.1159/000227651
ROILA F, 1998, J. Clin. Oncol., 16, 2937, 10.1200/JCO.1998.16.9.2937
TYSON LB, 1994, Am. J. Clin. Oncol., 17, 269, 10.1097/00000421-199406000-00018
ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery, 1999, J. Health-Syst. Pharm., 56, 729, 10.1093/ajhp/56.8.729
National Comprehensive Cancer Network, 1997, Oncology, 11, 57
HESKETH PJ, 1995, J. Clin. Oncol, 13, 2117, 10.1200/JCO.1995.13.8.2117
KAIZER L, 1994, J. Clin. Oncol., 12, 1050, 10.1200/JCO.1994.12.5.1050
GEBBIA V, 1994, Cancer, 74, 1945, 10.1002/1097-0142(19941001)74:7<1945::AID-CNCR2820740720>3.0.CO;2-C
MARKMAN M, 1997, J. Cancer Res. Clin. Oncol., 123, 224, 10.1007/BF01240319
BONNETERRE J, 1993, European Conference on Clinical Oncology Jerusalem, Israel, 14
JANTUNEN IT, 1993, Eur. J. Cancer, 29, 1669, 10.1016/0959-8049(93)90101-K
MASSIDDA B, 1996, J. Chem other., 8, 237
Glaxo Wellcome, Inc. Zofran package insert. Research Triangle Park, NC, USA (January 1999).
KRZAKOWSKI M, 1998, v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. AntiCancer Drugs, 9, 593
SPECTOR JI, 1998, Oncologist, 3, 432, 10.1634/theoncologist.3-6-432
FRANCHI M, 1995, Oncology, 52, 509, 10.1159/000227521
SMITH DB, 1991, Lancet, 338, 487, 10.1016/0140-6736(91)90555-4
CAMPORA E, 1995, Eur. J. Cancer, 31, 1720, 10.1016/0959-8049(95)00313-8
BOSNJAK SM, 1996, J. Chemother., 8, 315, 10.1179/joc.1996.8.4.315
CARMICHAEL J, 1988, Br. J. Cancer, 58, 266, 10.1038/bjc.1988.236
CASSIDY J, 1988, Br. J. Cancer, 58, 275, 10.1038/bjc.1988.278
GUMBRELL LA, 1988, Br. J. Cancer, 58, 274
ABBOTT B, 1999, Bone Marrow Transplant., 23, 265, 10.1038/sj.bmt.1701565
FRAKES LA, 1997, Bone Marrow Transplant., 20, 473, 10.1038/sj.bmt.1700911
BLEIBERG HH, 1995, Clin. Ther., 17, 38, 10.1016/0149-2918(95)80005-0
MARKMAN M, 1998, GynecoL Oncol, 71, 113, 10.1006/gyno.1998.5168
HERON JF, 1994, Ann. Oncol., 5, 579, 10.1093/oxfordjournals.annonc.a058927
KRIS MG, 1994, GRALLA RJ eta].: Dose-rangingevaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin. Clin. Oncol., 12, 1045
HARMAN GS, 1996, Cancer Chemother. Pharmacol., 38, 323, 10.1007/s002800050490
WHITMORE JB, 1998, Support Care Cancer, 6, 473, 10.1007/s005200050197
Hoechst Marion Roussel, Inc. Anzemet package insert. Kansas City, MO, USA (October 1997).
10.1002/(SICI)1097-0142(19970315)79:6<1216::AID-CNCR22>3.0.CO;2-1
GROTE TJ, 1997, Oral dolasetron dose response study group. Cancer J. ScL Am., 3, 45
FAUSER AA, 1996, Eur. J. Cancer, 32, 1523, 10.1016/0959-8049(96)00132-3
AUDHUY B, 1996, Eur. J. Cancer, 32, 807, 10.1016/0959-8049(96)00025-1
GEBBIA V, 1994, Cancer, 74, 1945, 10.1002/1097-0142(19941001)74:7<1945::AID-CNCR2820740720>3.0.CO;2-C
ITALIAN GROUP FOR ANTIEMETIC RESEARCH, 1995, Ann. Oncol., 6, 805, 10.1093/oxfordjournals.annonc.a059320
MANTOVANI G, 1996, Cancer, 77, 941, 10.1002/(SICI)1097-0142(19960301)77:5<941::AID-CNCR21>3.0.CO;2-2
MARTONI A, 1996, Eur. J. Cancer, 32, 82, 10.1016/0959-8049(95)00519-6
MARTY M KLEISBAUER J-P, 1995, AntiCancer Drugs, 6, 15, 10.1097/00001813-199502001-00004
HESKETH P, 1996, J. Clin. Oncol., 14, 2242, 10.1200/JCO.1996.14.8.2242
NOBLE A, 1994, Eur. J. Cancer, 30, 1083, 10.1016/0959-8049(94)90461-8
GRALLA RJ, 1998, J. Clin. Oncol, 16, 1568, 10.1200/JCO.1998.16.4.1568
NAVARI R, 1995, J. Clin. Oncol., 13, 1242, 10.1200/JCO.1995.13.5.1242
BONNETERRE J, 1995, Bull. Cancer, 82, 1038
CAMPORA E, 1994, Minerva Medica, 85, 25
JANTUNEN IT, 1993, Eur. J. Cancer, 29, 1669, 10.1016/0959-8049(93)90101-K
JANTUNEN IT, 1992, Acta Oncol, 31, 573, 10.3109/02841869209088309
MASSIDDA B, 1995, Support Care Cancer, 3, 340
PEREZ EA, 1998, Cancer J. Sci. Am., 4, 52
STEWART A, 1995, Oncology, 52, 202, 10.1159/000227458
PEREZ EA, 1998, J. Clin. Oncol., 16, 754, 10.1200/JCO.1998.16.2.754
KALAYCIO M, 1998, J. Cancer Res. Clin. Oncol., 124, 265, 10.1007/s004320050164
YALCIN S, 1999, Am. J. Clin. Oncol., 22, 94, 10.1097/00000421-199902000-00023
ANTIEMETIC SUBCOMMITTEE OF THE MULTINATIONAL ASSOCIATEION OF SUPPORTIVE CARE IN CANCER, 1998, Ann. Oncol., 9, 811, 10.1023/A:1008471812316
NOLTE MJ, 1998, J. Clin. Oncol., 16, 771, 10.1200/JCO.1998.16.2.771
HESKETH PJ, 1997, J. Clin. Oncol, 15, 103, 10.1200/JCO.1997.15.1.103
GANDARA DR, 1998, Support Care Cancer, 6, 237, 10.1007/s005200050160
GRALLA RJ, 1999, J. Clin. Oncol., 17, 2971, 10.1200/JCO.1999.17.9.2971
Data on file. SmithKline Beecham Pharmaceuticals. Kytril package insert. Philadelphia, PA, USA (April 1999).
